Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

STO/BIOVIC.B stock hub

STO/BIOVIC.B has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

STO/BIOVIC.Bis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
103.6M
Nasdaq Stockholm
Market data

Price

Recent price action with selectable time range.

STO/BIOVIC.BSTO/BIOVIC.B
—
Loading chart…
In the news

Latest news · STO/BIOVIC.B

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-83.9
P25 n/aP50 n/aP75 n/a
ROIC-50.8
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All STO/BIOVIC.B market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
176
Groups with data
11
Currency
SEK
Showing 176 of 176 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Sweden
Country code
SE
Employees
24
Employees Change
-3%
Employees Change Percent
-11.11
Enterprise value
SEK 20.2M
Exchange
Nasdaq Stockholm
Financial currency
SEK
First seen
2026-05-10
Industry
Biotechnology
Isin
SE0008613731
Last refreshed
2026-05-10
Market cap
SEK 103.6M
Price
SEK 0.36
Price currency
SEK
Rev Per Employee
455,208.33x
Sector
Healthcare
Sic
2835
Symbol
sto/BIOVIC.B
Website
https://www.biovica.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-69%
EV Earnings
-0.28x
EV/FCF
-0.31x
EV/Sales
1.85x
FCF yield
-62.64%
P/B ratio
0.98x
P/S ratio
9.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

17
MetricValue
Gross margin
103.08%
Gross Profit
SEK 11.3M
Gross Profit Growth
63.6%
Gross Profit Growth Q
64.69%
Gross Profit Growth3 Y
32.48%
Gross Profit Growth5 Y
4.37%
Net Income
SEK -71.5M
Net Income Growth Quarters
7%
Net Income Growth Years
1%
Pretax Margin
-659.51%
Profit Per Employee
SEK -3M
ROA
-43.18
Roa5y
-38.23
ROCE
-67.81
ROE
-83.92
Roe5y
-76.99
ROIC
-50.82

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

11
MetricValue
Cagr1y
-56.5%
Cagr3y
-61.79%
Cagr5y
-60.79%
EPS Growth Quarters
11
EPS Growth Years
2
Revenue Growth
33.38x
Revenue Growth Q
45.69x
Revenue Growth Quarters
5x
Revenue Growth Years
3x
Revenue Growth3 Y
24.98x
Revenue Growth5 Y
3.21x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
SEK 0.1
Assets
SEK 126.5M
Cash
SEK 88.2M
Current Assets
SEK 96.4M
Current Liabilities
SEK 17.8M
Debt
SEK 4.8M
Debt Equity
SEK 0.05
Debt FCF
SEK -0.07
Equity
SEK 105.9M
Liabilities
SEK 20.6M
Long Term Assets
SEK 30.1M
Long Term Liabilities
SEK 2.8M
Net Cash
SEK 83.4M
Net Cash By Market Cap
SEK 80.47
Net Cash Growth
123.01%
Net Debt Equity
SEK -0.79
Tangible Book Value
SEK 83M
Tangible Book Value Per Share
SEK 0.28
WACC
9.81

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
5.42
Net Working Capital
SEK -6.9M
Quick ratio
5.3
Working Capital
SEK 78.6M
Working Capital Turnover
SEK 0.2

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-112.15%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
-56.47%
200-day SMA
0.49
3Y total return
-94.42%
50-day SMA
0.34
50-day SMA vs 200-day SMA
50under200
5Y total return
-99.07%
All Time High
69
All Time High Change
-99.49%
All Time High Date
2021-07-12
All Time Low
0.27
All Time Low Change
31.48%
All Time Low Date
2026-03-06
ATR
0.04
Beta
1.09
Beta1y
1.55
Beta2y
1.26
Ch YTD
-4.05
High
0.36
High52
1.18
High52 Date
2025-05-19
High52ch
-69.92%
Low
0.32
Low52
0.27
Low52 Date
2026-03-09
Low52ch
31.48%
Ma50ch
3.26%
Price vs 200-day SMA
-28.12%
RSI
52.69
RSI Monthly
28.64
RSI Weekly
40.36
Sharpe ratio
-0.5x
Sortino ratio
-0.61
Total Return
-112.15%
Tr YTD
-4.05
Tr1m
-3.27%
Tr1w
11.99%
Tr3m
-20.05%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
SEK -73.7M
Operating margin
-674.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
252,274,205%
Net Borrowing
-3,237,000
Shares Insiders
8.12%
Shares Institutions
4.38%
Shares Out
291,911,199
Shares Qo Q
12.52%
Shares Yo Y
112.15%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

50
MetricValue
Adjusted FCF
SEK -64.9M
Average Volume
358,740x
Bv Per Share
0.36
CAPEX
SEK -264,000
Ch1m
-3.27
Ch1w
11.99
Ch1y
-59.84
Ch3m
-20.05
Ch3y
-94.86
Ch5y
-99.15
Ch6m
-39.63
Change
11.64%
Change From Open
6.29
Close
0.32
Days Gap
5.03
Depreciation Amortization
696,000
Dollar Volume
146,484
Earnings Date
2026-06-17
EBIT
SEK -73.7M
EBITDA
SEK -73M
EPS
SEK -0.38
F Score
4
FCF
SEK -64.9M
FCF EV Yield
-320.69x
FCF Per Share
SEK -0.22
Financing CF
110,136,000
Fiscal Year End
April
Founded
2,008
Income Tax
SEK -547,000
Investing CF
-264,000
Is Primary Listing
1
Last Earnings Date
2026-03-18
Last Report Date
2026-01-31
Ma150
0.44
Ma150ch
-20.05%
Ma20
0.34
Ma20ch
4.04%
Net CF
44,713,000
Next Earnings Date
2026-06-17
Open
0.33
Position In Range
94.87
Ppne
4,882,000
Price Date
2026-05-08
Ptbv Ratio
1.25
Relative Volume
1.13x
Revenue
10,925,000x
Tax By Revenue
-5.01x
Tr6m
-39.63%
Volume
412,631
Z Score
-3.96
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does STO/BIOVIC.B pay a dividend?

Capital-return profile for this ticker.

Performance

STO/BIOVIC.B stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-56.5%
S&P 500 1Y: n/a
3Y total return
-94.4%
S&P 500 3Y: n/a
5Y total return
-99.1%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns STO/BIOVIC.B?

Insider, institutional, and short-interest positioning.

Institutional ownership
+4.4%
Share of float held by funds and institutions
Insider ownership
+8.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+112.1%
Negative means the company is buying back shares.
Technical

STO/BIOVIC.B momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
52.7
Neutral momentum band
Price vs 200-day MA
-28.1%
50/200-day relationship not available
Beta (5Y)
1.09
Moves roughly with the market
Sharpe ratio
-0.50
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About STO/BIOVIC.B

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sto/BIOVIC.B stock rating?

sto/BIOVIC.B is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sto/BIOVIC.B analysis?

The full report lives at /stocks/sto/BIOVIC.B/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sto/BIOVIC.B?

The latest report frames sto/BIOVIC.B around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sto/BIOVIC.B page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.